Clinical Trial

Repeated CBD Administration and Cannabis Outcomes

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This outpatient study examines how cannabidiol (CBD) affects the behavioral and pain-relieving effects of cannabis.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-06
Trial Details
NCT Number NCT07434895
Lead Sponsor Hannah Harris
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Cannabis, Abuse Liability, Experimental Pain in Healthy Human Participants
Enrollment 23 participants
Start Date 2026-08-05
Primary Completion 2029-12-01 (estimated)
Study Completion 2029-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-12